Doxorubicin sensitizes breast cancer cells to natural killer cells in connection with increased Fas receptors-Reference-Cited by-同舟云学术

Doxorubicin sensitizes breast cancer cells to natural killer cells in connection with increased Fas receptors

Published:2022-02-01 Issue:3 Volume:49 Page:
ISSN:1107-3756
Container-title:International Journal of Molecular Medicine
language:
Short-container-title:Int J Mol Med

Author:

Sawasdee Nunghathai¹,Wattanapanitch Methichit²,Thongsin Nontaphat²,Phanthaphol Nattaporn¹,Chiawpanit Chutipa³,Thuwajit Chanitra⁴,Yenchitsomanus Pa-Thai¹,Panya Aussara³

Affiliation:

1. Siriraj Center of Research Excellence for Cancer Immunotherapy, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand

2. Siriraj Center for Regenerative Medicine, Research Department, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand

3. Department of Biology, Industry and Medicine, Faculty of Science, Chiang Mai University, Chiang Mai 50200, Thailand

4. Department of Immunology, Faculty of Medicine Siriraj Hospital, Mahidol University, Bangkok 10700, Thailand

Publisher

Spandidos Publications

Subject

Genetics,General Medicine

Reference55 articles.

1. Global cancer statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. Breast cancer in Thailand: Policy and health system challenges to universal healthcare;Lakha;Health Policy Plan,2020

3. Treating Breast Cancerhttps//:www.cancer.org/cancer/breast-cancer/treatment.html Accessed October 23, 2021

4. Influence of tumour stage at breast cancer detection on survival in modern times: Population based study in 173,797 patients;Saadatmand;BMJ,2015

5. Tumor-related prognostic factors for breast cancer;Donegan;CA Cancer J Clin,1997

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Application of nanoparticles in breast cancer treatment: a systematic review;Naunyn-Schmiedeberg's Archives of Pharmacology;2024-05-03

2. Impact of doxorubicin-loaded ferritin nanocages (FerOX) vs. free doxorubicin on T lymphocytes: a translational clinical study on breast cancer patients undergoing neoadjuvant chemotherapy;Journal of Nanobiotechnology;2024-04-15

3. Decoding cell death signalling: Impact on the response of breast cancer cells to approved therapies;Life Sciences;2024-04

4. Display of Polyvalent Hybrid Antibodies on the Cell Surface for Enhanced Cell Recognition;Small Methods;2023-12-17

5. Remodeled tumor immune microenvironment (TIME) parade via natural killer cells reprogramming in breast cancer;Life Sciences;2023-10